Genor Biopharma
China - ShanghaiPharmaceutical
Focus: Genor Biopharma is a Shanghai-based biopharmaceutical company specializing in monoclonal antibodies, fusion proteins, and biologics targeting oncology and immunology indications. The company maintains an active clinical pipeline with multiple programs across Phase 1–3 development.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Genor Biopharma
AI assessmentNot HiringNo open roles listed right now. Follow Genor Biopharma to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthStrong
Pipeline
Late-stage
4 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
GB222 3mg/kg
Brain TumorClinical Trials (1)
NCT04178057Phase I Clinical Study of GB222 to Evaluate the Safety, Tolerability and PK Profiles.
Phase 1Help build intelligence for Genor Biopharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.